FLJ45513: Potential Drug Target Or Biomarker for Neurodegenerative Diseases

Target Name: FLJ45513

NCBI ID: G729220

FLJ45513

Other Name(s): uncharacterized LOC729220 | HCG2045601 | Uncharacterized protein LOC729220 | Uncharacterized LOC729220

FLJ45513: Potential Drug Target Or Biomarker for Neurodegenerative Diseases

FLJ45513 is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. Its full name isflj45513, which consists of 455 amino acid residues.FLJ45513 is a small molecule that has been shown to interact with several protein tyrosine kinases, including PDGF signaling pathway.

The PDGF signaling pathway is a critical pathway that regulates cell growth, differentiation, and survival. It is involved in the development and maintenance of tissues and organs, including the brain and nervous system. The PDGF signaling pathway is also involved in the regulation of cell survival and proliferation, as well as in the regulation of angiogenesis.

FLJ45513 has been shown to interact with several PDGF signaling pathway proteins, including PDGF-尾, PDGF-纬, and PDGF-未. These interactions have been shown to play a role in the regulation of cellular processes such as cell survival, proliferation, and angiogenesis.

FLJ45513 has also been shown to interact with several transcription factors, including NF-kappa-B. The NF-kappa-B signaling pathway is involved in the regulation of gene expression and is involved in the development and maintenance of tissues and organs.

FLJ45513 has also been shown to interact with several signaling proteins, including TGF-β. The TGF-β signaling pathway is involved in the regulation of cell growth, differentiation, and survival.

In conclusion, FLJ45513 is a protein that has been shown to interact with several proteins involved in the PDGF, NF-kappa-B, and TGF-β signaling pathways. These interactions suggest that FLJ45513 may be a drug target or biomarker for the development of neurodegenerative diseases, such as Alzheimer's disease, Parkinson's disease, and other disorders. Further research is needed to fully understand the role of FLJ45513 in the regulation of cellular processes and to determine its potential as a drug target or biomarker.

Protein Name: Uncharacterized LOC729220

The "FLJ45513 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about FLJ45513 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets